found that, among 65 ERα + breast cancer samples treated with tamoxifen, menin-positive tumors (20 patients) had worse clinical outcome and were more resistant to tamoxifen than menin-negative tumors, suggesting that menin exerts oncogenic effects in these cases [15]. This evidence concerns the gene MEN1 and breast carcinoma.